全文获取类型
收费全文 | 302297篇 |
免费 | 40716篇 |
国内免费 | 2916篇 |
专业分类
耳鼻咽喉 | 6738篇 |
儿科学 | 8988篇 |
妇产科学 | 4922篇 |
基础医学 | 23723篇 |
口腔科学 | 4799篇 |
临床医学 | 41354篇 |
内科学 | 78441篇 |
皮肤病学 | 10531篇 |
神经病学 | 28639篇 |
特种医学 | 12992篇 |
外国民族医学 | 14篇 |
外科学 | 64470篇 |
综合类 | 2176篇 |
现状与发展 | 72篇 |
一般理论 | 109篇 |
预防医学 | 18456篇 |
眼科学 | 6484篇 |
药学 | 10920篇 |
中国医学 | 244篇 |
肿瘤学 | 21857篇 |
出版年
2024年 | 747篇 |
2023年 | 5491篇 |
2022年 | 2584篇 |
2021年 | 6233篇 |
2020年 | 7817篇 |
2019年 | 5136篇 |
2018年 | 10655篇 |
2017年 | 9795篇 |
2016年 | 11210篇 |
2015年 | 11648篇 |
2014年 | 20028篇 |
2013年 | 21885篇 |
2012年 | 15451篇 |
2011年 | 16132篇 |
2010年 | 16217篇 |
2009年 | 19622篇 |
2008年 | 15203篇 |
2007年 | 13928篇 |
2006年 | 16228篇 |
2005年 | 13635篇 |
2004年 | 12081篇 |
2003年 | 10445篇 |
2002年 | 10140篇 |
2001年 | 5792篇 |
2000年 | 4724篇 |
1999年 | 5186篇 |
1998年 | 5422篇 |
1997年 | 4874篇 |
1996年 | 4542篇 |
1995年 | 4334篇 |
1994年 | 2986篇 |
1993年 | 2513篇 |
1992年 | 2599篇 |
1991年 | 2525篇 |
1990年 | 2049篇 |
1989年 | 2104篇 |
1988年 | 1886篇 |
1987年 | 1704篇 |
1986年 | 1735篇 |
1985年 | 1550篇 |
1984年 | 1458篇 |
1983年 | 1289篇 |
1982年 | 1450篇 |
1981年 | 1248篇 |
1980年 | 1072篇 |
1979年 | 955篇 |
1978年 | 964篇 |
1977年 | 915篇 |
1976年 | 735篇 |
1974年 | 729篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
41.
42.
43.
44.
Thomas J. Cahill Shehan Hettiaratchy Alex Clarke Peter E.M. Butler 《Transplantation reviews (Orlando, Fla.)》2006,20(2):76-81
Animal models have traditionally provided the basis for preliminary investigation of new techniques prior to trials taking place in human subjects. The timing of when to proceed with human trials is difficult, as the accuracy of preclinical models can only be determined with hindsight. This review outlines the progression from transplantation in animal models to man. Now that many transplant procedures are well established, it is possible to assess the predictive value and limitations of animal models. These results are of great importance in the current debate about composite tissue allotransplantation (CTA) and in particular facial transplantation. This progression of CTA from animal models to man is outlined and compared with early renal, cardiac, and liver transplants. There is some evidence to suggest that animal models may have been misleading in CTA and that this has effectively delayed the transition to humans. The role for animal models in facial transplantation, which is currently making the step to clinical trials, is discussed. 相似文献
45.
Timothy C. Evans MD PhD ; Keren H. Wick PhD ; Douglas M. Brock PhD ; Douglas C. Schaad PhD ; Ruth Ballweg MPA PA-C 《The Journal of rural health》2006,22(3):212-219
CONTEXT: The physician assistant profession has been moving toward requiring master's degrees for new practitioners, but some argue this could change the face of the discipline. PURPOSE: To see if there is an association between physician assistants' academic degrees and practice in primary care, in rural areas, and with the medically underserved. METHODS: Surveys were sent to 880 graduates of the first 32 University of Washington physician assistant classes through 2000. Respondents noted their academic degree at program entry and the highest degree attained at any time up to the time of survey. Relationships between practice characteristics and academic degree levels were tested by unadjusted odds ratios and logistic regression after controlling for year of graduation and sex. RESULTS: Of the 478 respondents, 54% worked in primary care, about 30% practiced in nonmetropolitan communities, and 42% reported providing care for the medically underserved. Respondents with no degree (33% of total at entry, 24% at survey) were significantly more likely than degree holders to work in primary care and nonmetropolitan areas. Respondents with no degree at program entry were significantly more likely, and those with no degree at the time of the survey were marginally more likely, to self-report work with the medically underserved. CONCLUSION: Respondents with no academic degree are significantly more likely to demonstrate a commitment to primary, rural, and underserved health care. These findings may inform the national debate about the impact of required advanced degrees on the practice patterns of nonphysician providers. 相似文献
46.
This article describes the proceedings of the 2006 Annual Meeting of the Fetal Alcohol Spectrum Disorders Study Group (FASDSG), which was held in Baltimore, Maryland on June 24, 2006. The meeting was held in conjunction with the annual meeting of the Research Society on Alcoholism and was supported by a grant from the National Institute on Alcohol Abuse and Alcoholism. The 2005-2006 FASDSG officers, Daniel J. Bonthius (President), Heather Carmichael Olson (Vice-President), and Jennifer Thomas (Secretary-Treasurer), organized the meeting. Nationally prominent speakers delivered plenary lectures on topics of newborn screening, ethics, and neuroscience. Selected members of the FASDSG provided brief scientific data (FASt) reports, describing new research findings. Representatives from national agencies involved in fetal alcohol syndrome (FAS) research, treatment, and prevention provided updates regarding priorities, funding, and agency activities. Presentations were also made by the 2006 Student Merit Award recipient and by the 2006 Rosett Award recipient. The meeting served as a forum for clinicians, neuroscientists, psychologists, social scientists, and other professionals to discuss recent advances in FAS research and to identify the most important gaps in the understanding of alcohol-induced teratology. 相似文献
47.
48.
Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation 总被引:2,自引:0,他引:2
Rolf N. Barth Christina A. Janus Christine A. Lillesand Nancy A. Radke John D. Pirsch Bryan N. Becker Luis A. Fernandez L. Thomas Chin Yolanda T. Becker Jon S. Odorico Anthony M. D''Alessandro Hans W. Sollinger Stuart J. Knechtle 《Transplant international》2006,19(11):885-892
Campath-1H (alemtuzumab) induction was used for renal transplantation in combination with sirolimus as immunosuppression. We previously reported a high (28%) rate of early rejection with this regimen, and now report 3-year outcomes. Twenty-nine patients were recipients of either deceased donor or non-HLA (Human Leukocyte Antigen) identical living donor primary renal allografts. Clinical parameters including infection, malignancy, kidney function, and kidney histology were followed prospectively for 3 years. Three-year cumulative graft and patient survival were 96% and 100%, respectively. Twenty patients were maintained on steroid-free immunosuppressive regimens, and 15 patients were maintained on monotherapy for immunosuppression (12 on sirolimus). No serious infectious complications were observed and two patients developed basal cell skin cancer. The 3-year results of our initial pilot study demonstrate good graft (96%) and patient (100%) outcomes. Campath-1H induction has yielded a high proportion of patients maintained on immunosuppressive monotherapy (57%) without serious infectious- and no malignancy-related complications. The reported regimen yielded novel insights into both Campath-1H and sirolimus therapy in renal transplantation. Because of the higher incidence of early rejection, we recommend a modified strategy of immunosuppression including a brief course of a calcineurin inhibitor. 相似文献
49.
This review discusses treatment options for men with premature ejaculation (PE), a common sexual dysfunction characterized
by short ejaculatory latency, decreased sexual satisfaction, and distress. For a number of reasons, including embarrassment
and the belief that PE is a normal part of aging, that it has no effective treatment, or that it will resolve itself, few
men with PE seek treatment. Although several treatment options exist (eg, behavioral, cognitive, and sex therapy methods;
desensitizing drugs; off-label use of antidepressants, phosphodiesterase type 5 inhibitors, or à-blockers), the majority of
men with PE are not satisfied with their results. New pharmacologic drugs develped specifically for the treatment of PE are
undergoing evaluation in clinical trials. For example, recent clinical research studies have revealed on-demand administration
of one such drug, dapoxetine, which achieved significant improvements in ejaculatory latency, control over ejaculation, and
satisfaction with sexual intercourse. In addition, partners of men who received dapoxetine likewise reported improved satisfaction
with sexual intercourse. Future studies may reveal that integration of pharmacologic drugs with psychologic and/or behavioral
therapy techniques may be the optimal approach to the management of PE. PE is a treatable condition, and new drugs in development
may provide benefits over those available. 相似文献
50.